Panobinostat and Carfilzomib in Treating Participants With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT01301807 · COMPLETED

Trial details

NCT number: NCT01301807
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Secretory Plasma Cell Myeloma Plasmacytosis Recurrent Plasma Cell Myeloma Refractory Plasma Cell Myeloma

Start date: 2011-07-28
Primary completion: 2019-11-07
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.